Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New treatments for chronic urticaria
Pavel Kolkhir, Sabine Altrichter, Melba Muñoz, et al.
Annals of Allergy Asthma & Immunology (2019) Vol. 124, Iss. 1, pp. 2-12
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Urticaria
Pavel Kolkhir, Ana M. Giménez‐Arnau, Kanokvalai Kulthanan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020
Marcus Maurer, Kilian Eyerich, Stefanie Eyerich, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 5, pp. 321-333
Open Access | Times Cited: 155
Pruritus as a Distinctive Feature of Type 2 Inflammation
Simone Garcovich, Martina Maurelli, Paolo Gisondi, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 303-303
Open Access | Times Cited: 119
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Joakim S. Dahlin, Marcus Maurer, Dean D. Metcalfe, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 83-99
Open Access | Times Cited: 112
Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control
Karsten Weller, Tamara Donoso, Markus Magerl, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 6, pp. 2050-2057.e4
Closed Access | Times Cited: 83
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
Mario Sánchez‐Borges, Ignacio J. Ansotegui, Ilaria Baiardini, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 6, pp. 100533-100533
Open Access | Times Cited: 78
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma
Rory Chan, Kirsten Stewart, Rasads Misirovs, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1497-1505
Open Access | Times Cited: 49
Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases
Martin Metz, Pavel Kolkhir, Sabine Altrichter, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 37-51
Open Access | Times Cited: 30
IgE, IgE Receptors and Anti-IgE Biologics: Protein Structures and Mechanisms of Action
James M. McDonnell, B. Dhaliwal, Brian J. Sutton, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 255-275
Open Access | Times Cited: 26
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
Kai‐Wen Chuang, Che-Yuan Hsu, Shiu‐Wen Huang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2382-2389.e3
Closed Access | Times Cited: 25
Urticaria and Angioedema Across the Ages
Sarbjit S. Saini, Marissa Shams, Jonathan A. Bernstein, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 6, pp. 1866-1874
Closed Access | Times Cited: 61
The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria
Yuhki Yanase, Shunsuke Takahagi, Koichiro Ozawa, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1759-1759
Open Access | Times Cited: 50
Chronic Urticaria
David M. Lang
New England Journal of Medicine (2022) Vol. 387, Iss. 9, pp. 824-831
Closed Access | Times Cited: 31
Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
S. Wang, Ya‐Gang Zuo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021*
R.A. Sabroe, Frances Lawlor, Clive Grattan, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 398-413
Open Access | Times Cited: 35
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study
Marcus Maurer, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Allergy (2021) Vol. 77, Iss. 7, pp. 2175-2184
Open Access | Times Cited: 35
Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines
Jasmine Chang, Leila Cattelan, Moshe Ben‐Shoshan, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 187-199
Open Access | Times Cited: 33
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Gil Yosipovitch, Georgia Biazus Soares, Omar Mahmoud
Dermatology and Therapy (2023) Vol. 13, Iss. 8, pp. 1647-1660
Open Access | Times Cited: 14
Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor
Yuhki Yanase, Yoshimi Matsuo, Shunsuke Takahagi, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 3, pp. 1101-1104.e7
Open Access | Times Cited: 34
Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis
Lina Belmesk, Anastasiya Muntyanu, Emmanuelle Cantin, et al.
Journal of Cutaneous Medicine and Surgery (2021) Vol. 26, Iss. 1, pp. 33-49
Open Access | Times Cited: 32
Evaluation of Pharmacologic Treatments for H1 Antihistamine–Refractory Chronic Spontaneous Urticaria
Surapon Nochaiwong, Mati Chuamanochan, Chidchanok Ruengorn, et al.
JAMA Dermatology (2021) Vol. 157, Iss. 11, pp. 1316-1316
Open Access | Times Cited: 27
Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
Niki Papapostolou, Paraskevi Xepapadaki, Alexander Katoulis, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 19
Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels
Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 9, pp. 2427-2441
Open Access | Times Cited: 4
Überbrückung der Versorgungslücke durch Telemedizin: Pilotstudie zur Akzeptanz und Nutzung der Teledermatologie bei Urtikaria
Michael J. Hindelang, Sebastian Sitaru, Chiara Fischer, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 40-53
Open Access
Herbal Remedies for Urticaria: A Comprehensive Global Perspective on Traditional Practices, Efficacy, and Future Directions
Lakshman Kumar Dogiparthi, Sarad Pawar Naik Bukke, Mokshitha Pachipala, et al.
Natural Product Communications (2025) Vol. 20, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top